2,866 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,179 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,179 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.15%65.99% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,866
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
451
$9.74M
452
$9.73M
453
$9.6M
454
$9.59M
455
$9.58M
456
$9.58M
457
$9.54M
458
$9.51M
459
$9.48M
460
$9.38M
461
$9.38M
462
$9.36M
463
$9.36M
464
$9.33M
465
$9.31M
466
$9.21M
467
$9.19M
468
$9.18M
469
$9.15M
470
$9.14M
471
$9.12M
472
$9.08M
473
$9.07M
474
$9.06M
475
$9.06M